Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Hydroxychloroquine + FOLFIRI + Bevacizumab for Colorectal Cancer
Recruiting1 awardPhase 2
Toronto, Ontario
This trial tests a new chemo+drug combo to treat mCRC. Up to 155 patients will be screened, up to 31 will receive the combo until progression, side effects, etc.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.